Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 5.02
RVP's Cash to Debt is ranked higher than
60% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.81 vs. RVP: 5.02 )
Ranked among companies with meaningful Cash to Debt only.
RVP' s Cash to Debt Range Over the Past 10 Years
Min: 0.06  Med: 5.39 Max: 24.08
Current: 5.02
0.06
24.08
Equity to Asset 0.75
RVP's Equity to Asset is ranked higher than
70% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.62 vs. RVP: 0.75 )
Ranked among companies with meaningful Equity to Asset only.
RVP' s Equity to Asset Range Over the Past 10 Years
Min: 0.01  Med: 0.73 Max: 0.86
Current: 0.75
0.01
0.86
F-Score: 3
Z-Score: 5.62
M-Score: -2.34
WACC vs ROIC
9.62%
-22.47%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -10.94
RVP's Operating margin (%) is ranked lower than
69% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.98 vs. RVP: -10.94 )
Ranked among companies with meaningful Operating margin (%) only.
RVP' s Operating margin (%) Range Over the Past 10 Years
Min: -37.83  Med: -19.00 Max: -6.25
Current: -10.94
-37.83
-6.25
Net-margin (%) 14.75
RVP's Net-margin (%) is ranked higher than
83% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.15 vs. RVP: 14.75 )
Ranked among companies with meaningful Net-margin (%) only.
RVP' s Net-margin (%) Range Over the Past 10 Years
Min: -34.57  Med: -13.78 Max: 6.63
Current: 14.75
-34.57
6.63
ROE (%) 19.72
RVP's ROE (%) is ranked higher than
87% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.01 vs. RVP: 19.72 )
Ranked among companies with meaningful ROE (%) only.
RVP' s ROE (%) Range Over the Past 10 Years
Min: -27.63  Med: -12.66 Max: 2.75
Current: 19.72
-27.63
2.75
ROA (%) 10.14
RVP's ROA (%) is ranked higher than
84% of the 203 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. RVP: 10.14 )
Ranked among companies with meaningful ROA (%) only.
RVP' s ROA (%) Range Over the Past 10 Years
Min: -16.75  Med: -6.97 Max: 4.48
Current: 10.14
-16.75
4.48
ROC (Joel Greenblatt) (%) 30.53
RVP's ROC (Joel Greenblatt) (%) is ranked higher than
76% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.53 vs. RVP: 30.53 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
RVP' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -66.55  Med: -27.23 Max: 11.27
Current: 30.53
-66.55
11.27
Revenue Growth (3Y)(%) 1.20
RVP's Revenue Growth (3Y)(%) is ranked lower than
63% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. RVP: 1.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
RVP' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -7.8  Med: 4.65 Max: 15.1
Current: 1.2
-7.8
15.1
» RVP's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-14)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

RVP Guru Trades in Q2 2015

Jim Simons 36,000 sh (-28.14%)
» More
Q3 2015

RVP Guru Trades in Q3 2015

Jim Simons 34,426 sh (-4.37%)
» More
Q4 2015

RVP Guru Trades in Q4 2015

Jim Simons 14,400 sh (-58.17%)
» More
Q1 2016

RVP Guru Trades in Q1 2016

Jim Simons 22,000 sh (+52.78%)
» More
» Details

Insider Trades

Latest Guru Trades with RVP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NAS:HBIOV, TSE:7702, BSP:CREM3, HKSE:00899, BKK:TOG, NAS:SIEN » details
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. It offers 1mL tuberculin; allergy antigen VanishPoint syringes; 3mL and 10mL VanishPoint syringes.

Retractable Technologies Inc was incorporated in Texas on May 9, 1994. The Company designs, develops, manufactures, and markets patented safety medical products for the healthcare industry. The Companys products with Notice of Substantial Equivalence to the U.S. Food and Drug Administration (FDA) and which are currently sold include the 1mL tuberculin; insulin; allergy antigen VanishPoint syringes; 3mL, 5mL, and 10mL VanishPoint syringes; the VanishPoint blood collection tube holder; the VanishPoint IV safety catheter; small diameter tube adapter; the Patient Safe syringe; the Patient Safe Luer Cap; and the VanishPoint Blood Collection Set. It is also selling autodisable syringes in the international market. The Companys VanishPoint safety products (consisting of 1mL tuberculin, insulin, and allergy antigen VanishPoint syringes; 0.5mL, 2ml, 3mL, 5mL, and 10mL VanishPoint syringes; VanishPoint autodisable syringe; the VanishPoint IV catheter; the VanishPoint blood collection tube holder; and the VanishPoint blood collection set. PatientSafe syringe products currently consist of 3mL, 5mL, 10mL, 20mL, 30mL, 60mL PatientSafe syringes and the PatientSafe luer cap. The PatientSafe syringe offers a patented design designed to protect patients by reducing the risk of bloodstream infections resulting from catheter hub contamination. The Company distributes its products throughout the U.S. and its territories through general line and specialty distributors. It also has trademark protection for the phrase The New Standard for Safety'. Its domestic competitors include BD and Covidien Ltd. (Covidien). Terumo Medical Corp. (Terumo), Smiths Medical, and B Braun are additional competitors with smaller market shares.

Ratios

vs
industry
vs
history
P/E(ttm) 14.00
RVP's P/E(ttm) is ranked higher than
84% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.90 vs. RVP: 14.00 )
Ranked among companies with meaningful P/E(ttm) only.
RVP' s P/E(ttm) Range Over the Past 10 Years
Min: 1.46  Med: 16.39 Max: 633.33
Current: 14
1.46
633.33
PE(NRI) 14.00
RVP's PE(NRI) is ranked higher than
83% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.90 vs. RVP: 14.00 )
Ranked among companies with meaningful PE(NRI) only.
RVP' s PE(NRI) Range Over the Past 10 Years
Min: 1.25  Med: 15.25 Max: 148
Current: 14
1.25
148
P/B 2.74
RVP's P/B is ranked lower than
52% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.69 vs. RVP: 2.74 )
Ranked among companies with meaningful P/B only.
RVP' s P/B Range Over the Past 10 Years
Min: 0.27  Med: 1.15 Max: 5.62
Current: 2.74
0.27
5.62
P/S 2.75
RVP's P/S is ranked lower than
51% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.59 vs. RVP: 2.75 )
Ranked among companies with meaningful P/S only.
RVP' s P/S Range Over the Past 10 Years
Min: 0.39  Med: 1.45 Max: 5.29
Current: 2.75
0.39
5.29
EV-to-EBIT 15.25
RVP's EV-to-EBIT is ranked higher than
65% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.76 vs. RVP: 15.25 )
Ranked among companies with meaningful EV-to-EBIT only.
RVP' s EV-to-EBIT Range Over the Past 10 Years
Min: -133.3  Med: -2.30 Max: 220.8
Current: 15.25
-133.3
220.8
EV-to-EBITDA 12.88
RVP's EV-to-EBITDA is ranked higher than
62% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.58 vs. RVP: 12.88 )
Ranked among companies with meaningful EV-to-EBITDA only.
RVP' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1487.3  Med: -2.30 Max: 38.6
Current: 12.88
-1487.3
38.6
Current Ratio 4.18
RVP's Current Ratio is ranked higher than
75% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. RVP: 4.18 )
Ranked among companies with meaningful Current Ratio only.
RVP' s Current Ratio Range Over the Past 10 Years
Min: 0.55  Med: 4.05 Max: 11.46
Current: 4.18
0.55
11.46
Quick Ratio 3.25
RVP's Quick Ratio is ranked higher than
76% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. RVP: 3.25 )
Ranked among companies with meaningful Quick Ratio only.
RVP' s Quick Ratio Range Over the Past 10 Years
Min: 0.22  Med: 3.25 Max: 10.86
Current: 3.25
0.22
10.86
Days Inventory 117.54
RVP's Days Inventory is ranked higher than
56% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 126.38 vs. RVP: 117.54 )
Ranked among companies with meaningful Days Inventory only.
RVP' s Days Inventory Range Over the Past 10 Years
Min: 83.71  Med: 98.26 Max: 133.86
Current: 117.54
83.71
133.86
Days Sales Outstanding 39.41
RVP's Days Sales Outstanding is ranked higher than
84% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.03 vs. RVP: 39.41 )
Ranked among companies with meaningful Days Sales Outstanding only.
RVP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 23.16  Med: 42.13 Max: 93.15
Current: 39.41
23.16
93.15
Days Payable 84.21
RVP's Days Payable is ranked higher than
65% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 55.30 vs. RVP: 84.21 )
Ranked among companies with meaningful Days Payable only.
RVP' s Days Payable Range Over the Past 10 Years
Min: 55.5  Med: 85.33 Max: 113.99
Current: 84.21
55.5
113.99

Valuation & Return

vs
industry
vs
history
Price/Net Cash 10.00
RVP's Price/Net Cash is ranked higher than
53% of the 53 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.73 vs. RVP: 10.00 )
Ranked among companies with meaningful Price/Net Cash only.
RVP' s Price/Net Cash Range Over the Past 10 Years
Min: 1.2  Med: 2.33 Max: 424.5
Current: 10
1.2
424.5
Price/Net Current Asset Value 4.52
RVP's Price/Net Current Asset Value is ranked higher than
64% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.84 vs. RVP: 4.52 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
RVP' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 0.81  Med: 1.82 Max: 100.33
Current: 4.52
0.81
100.33
Price/Tangible Book 2.76
RVP's Price/Tangible Book is ranked higher than
59% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.86 vs. RVP: 2.76 )
Ranked among companies with meaningful Price/Tangible Book only.
RVP' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.45  Med: 1.36 Max: 603.85
Current: 2.76
0.45
603.85
Price/Projected FCF 2.54
RVP's Price/Projected FCF is ranked lower than
66% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.89 vs. RVP: 2.54 )
Ranked among companies with meaningful Price/Projected FCF only.
RVP' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.19  Med: 1.44 Max: 154
Current: 2.54
0.19
154
Price/Median PS Value 1.91
RVP's Price/Median PS Value is ranked lower than
86% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.06 vs. RVP: 1.91 )
Ranked among companies with meaningful Price/Median PS Value only.
RVP' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.41  Med: 1.89 Max: 8.26
Current: 1.91
0.41
8.26
Price/Graham Number 1.30
RVP's Price/Graham Number is ranked higher than
72% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.42 vs. RVP: 1.30 )
Ranked among companies with meaningful Price/Graham Number only.
RVP' s Price/Graham Number Range Over the Past 10 Years
Min: 0.25  Med: 1.33 Max: 4.69
Current: 1.3
0.25
4.69
Earnings Yield (Greenblatt) (%) 6.60
RVP's Earnings Yield (Greenblatt) (%) is ranked higher than
79% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. RVP: 6.60 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
RVP' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.5  Med: 16.30 Max: 15871.2
Current: 6.6
0.5
15871.2

More Statistics

Revenue (TTM) (Mil) $29.30
EPS (TTM) $ 0.20
Beta1.06
Short Percentage of Float0.13%
52-Week Range $2.10 - 4.34
Shares Outstanding (Mil)29.65
» More Articles for RVP

Headlines

Articles On GuruFocus.com
Retractable Technologies Inc (RVP) CEO Thomas J Shaw buys 200,000 Shares Mar 16 2009 

More From Other Websites
RETRACTABLE TECHNOLOGIES INC Financials May 24 2016
RETRACTABLE TECHNOLOGIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 18 2016
Retractable Technologies, Inc. Reports Results for the First Quarter of 2016 May 17 2016
Retractable Technologies, Inc. Reports Results for the First Quarter of 2016 May 17 2016
RETRACTABLE TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report May 16 2016
Retractable Technologies, Inc. :RVP-US: Earnings Analysis: 2015 By the Numbers Apr 11 2016
RETRACTABLE TECHNOLOGIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 04 2016
RETRACTABLE TECHNOLOGIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 01 2016
Retractable Technologies, Inc. Reports Results for the Year 2015 Apr 01 2016
Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Convertible Preferred... Apr 01 2016
RETRACTABLE TECHNOLOGIES INC Files SEC form 10-K, Annual Report Mar 30 2016
Retractable Technologies, Inc.: Strong price momentum but will it sustain? Jan 29 2016
RETRACTABLE TECHNOLOGIES INC Files SEC form 8-K, Other Events Jan 28 2016
Oral Argument Calendared for Retractable Technologies, Inc. Jan 28 2016
RETRACTABLE TECHNOLOGIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 12 2016
Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Preferred Stock... Jan 11 2016
Retractable Technologies, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 21 2015
RETRACTABLE TECHNOLOGIES INC Files SEC form 8-K, Other Events Dec 11 2015
RETRACTABLE TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement Dec 09 2015
Evaluating the Technicals - Research on Hudson Technologies, Retractable Technologies, Spark... Dec 02 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)